Five things to know about acne treatment
Structured for search, voice, and AI overview extraction. These are the most frequently asked questions about acne — answered clearly before the full medical education begins.
What is acne and why does it matter for Indian skin?
Acne vulgaris is a chronic inflammatory condition of the pilosebaceous unit — the combined structure of a hair follicle and its attached oil (sebaceous) gland. It affects the face most commonly, but also the neck, chest, back, and shoulders where sebaceous glands are densely concentrated.
The condition typically begins during puberty when androgens increase sebum production, but it can persist through the twenties, thirties, and beyond — particularly in women with hormonal drivers such as PCOS or OCP changes. Adult acne in Indian women is more common than many patients realise, and it often has a different pattern from teenage acne.
In the Indian context, acne carries two layers of concern that are less prominent in lighter-skinned populations. First, the risk of post-inflammatory hyperpigmentation (PIH) — flat dark marks left by even mild inflammatory lesions — is significantly higher in Fitzpatrick III–V Indian skin. Second, Delhi's heat, humidity, pollution, and hard water create an aggravating environment that worsens both active acne and PIH recovery.
Acne is not caused by poor hygiene, eating oily food, or not washing enough. Over-washing and aggressive scrubbing actually damage the skin barrier and can worsen both acne and PIH. Understanding what acne truly is — and what it is not — is the starting point for every treatment decision.
How acne forms — step by step
- Step 1. Androgens stimulate sebaceous glands to produce excess sebum.
- Step 2. Dead skin cells shed abnormally and mix with sebum inside the follicle.
- Step 3. The follicle opening narrows or blocks — forming a comedone (whitehead or blackhead).
- Step 4. C. acnes bacteria, which normally live on skin, multiply rapidly inside blocked follicles.
- Step 5. The immune system responds to bacterial byproducts — creating redness, swelling, and pus.
- Step 6. Deep inflammation can damage surrounding dermis — leading to scars or triggering excess melanin — leading to PIH.
Who is most affected in India?
- Teenagers (12–19): nearly universal sebaceous activity
- Young adults (20–30): persistence, often hormonal
- Adult women (30–45): jawline, chin, cyclic patterns; often PCOS-linked
- People exposed to steroid creams (common OTC misuse in India)
- People using heavy hair oils or comedogenic products
- Those in high-humidity Delhi summers and pollution exposure
How acne appears on the skin
Not all pimples are the same condition. The type, depth, and distribution of acne lesions determine the treatment pathway. Correctly identifying what you have is the first clinical step.
Whiteheads
Closed comedones — follicles blocked by sebum and dead cells but covered by skin. They appear as small white or flesh-coloured bumps. Non-inflammatory; respond well to retinoids.
Blackheads
Open comedones where the blocked follicle is exposed to air, oxidising the sebum to black. Not caused by dirt. Squeezing rarely helps and can deepen blockage or create PIH.
Papules
Inflamed, tender red bumps with no visible pus. They indicate that immune response has begun inside the follicle. Picking spreads bacteria and worsens PIH risk significantly.
Pustules
Inflamed lesions with a visible pus-filled tip surrounded by a red ring. These are the classic "pimples." They sit near the skin surface and often respond to topical benzoyl peroxide and antibiotics.
Nodules
Large, deep, solid, painful lumps embedded within the skin. They involve deeper dermis layers and carry high scar risk. Topical treatment alone is usually insufficient. Often require oral treatment.
Cystic Acne
The most severe form — deep, pus-filled, very painful cysts that can be several centimetres wide. They damage surrounding dermis and have the highest risk of permanent scarring. Requires prompt medical evaluation.
Dark Marks (PIH)
Post-inflammatory hyperpigmentation — flat brownish or greyish marks that remain after an acne lesion resolves. Not a scar. More pronounced and slower to fade in Indian (Fitzpatrick III–V) skin. Treatable with correct products and time.
Back & Chest Acne
Body acne influenced by high sebaceous density, sweat retention, clothing friction, and gym equipment contact. Treatment formulations differ from facial acne — body skin tolerates stronger concentrations and different delivery methods.
How a single lesion forms
Acne is not a surface event. By the time you can see it, four biological things have already happened beneath the skin. Understanding them changes what treatments make sense.
Eight kinds of acne — they need different treatments
Most patients have a mix. The dermatologist's job is to identify what is dominant — that decides the plan.
Why acne develops — and why it keeps coming back
Multiple factors converge to create and worsen acne. Understanding your specific triggers is part of the dermatologist's diagnostic job — the same medication does not work the same way for every cause.
The four primary internal drivers
1. Excess sebum
Androgens — particularly testosterone and DHEA-S — increase sebaceous gland activity. This is why acne spikes at puberty, worsens with hormonal changes, and is often linked to PCOS in adult women. Sebum is not the enemy; excess sebum in combination with other factors is.
2. Abnormal follicle keratinisation
Dead skin cells normally shed regularly from inside the follicle. In acne-prone skin, this process is disrupted — cells accumulate and mix with sebum to form a comedone plug. This is why retinoids, which normalise cell turnover, are central to most acne treatment plans.
3. C. acnes proliferation
Cutibacterium acnes (C. acnes) normally lives on skin without causing problems. Inside a sebum-rich blocked follicle, it multiplies rapidly and releases enzymes and byproducts that trigger an immune response. Benzoyl peroxide and antibiotics act at this stage — but resistance to antibiotics is rising, making combination approaches essential.
4. Immune-mediated inflammation
The immune system releases cytokines in response to bacterial products and follicle rupture. This creates the visible redness, swelling, and pain of inflammatory acne. Deep inflammation — from nodules and cysts — damages surrounding dermis, creating the conditions for permanent scarring.
Hormonal triggers
Puberty androgens, PCOS (elevated testosterone/DHEA), OCP initiation or discontinuation, menstrual cycle fluctuation, perimenopause, and thyroid dysfunction. Hormonal acne typically presents on the lower face, jaw, and chin, often cyclically.
Delhi-specific aggravators
Delhi's environment creates a unique acne burden: high summer humidity promotes C. acnes proliferation; airborne pollution particles settle in pores and increase oxidative stress; hard water disrupts skin barrier function; heat and sweating extend the inflammatory phase; UVA/UVB exposure worsens PIH after every lesion. Patients in Delhi with acne face compounded triggers that a treatment plan must account for explicitly.
Product and occlusion triggers
Heavy hair oils, comedogenic moisturisers, full-coverage foundations, dirty makeup brushes, helmet straps, mask edges, phone screens, and tight high-neck collars can all trigger or worsen localised acne. A product audit is a standard part of the first consultation.
Medication triggers
Steroid creams applied to the face are a major and often unrecognised cause of steroid acne in India, where potent topical steroids are available over the counter. Oral steroids, anabolic steroids, lithium, phenytoin, and some B-complex vitamins can also trigger acne-like eruptions that require a different treatment approach.
Lifestyle and environmental factors
Stress elevates cortisol and androgen levels, worsening sebum and inflammation. Disrupted sleep impairs cortisol regulation. High-glycaemic foods and some dairy patterns may aggravate acne in susceptible individuals. These are modifiable contributors, not primary causes — managing them helps but does not replace medical treatment in moderate-to-severe acne.
Who is at higher risk — and why it matters clinically
Biological risk factors
- Family history of acne (especially severe or scarring)
- Elevated androgens (PCOS, congenital adrenal hyperplasia)
- Fitzpatrick IV–VI skin tone (higher PIH risk per inflammatory lesion)
- Age: puberty onset, persistent adult acne in women
- Hormonal fluctuation (menstrual cycle, pregnancy, perimenopause)
- Prior history of acne scarring or keloid tendency
Behavioural and product risk factors
- OTC steroid cream application to the face
- Repeated antibiotic use without maintenance therapy
- Aggressive scrubbing or physical exfoliation on inflamed skin
- Heavy comedogenic skincare (coconut oil, petroleum-based creams)
- Sleeping with makeup, using unwashed makeup brushes
- Delaying treatment until scars have already formed
- Following unverified social-media skincare trends
Environmental and contextual risk
- Delhi pollution and particulate matter exposure
- High-humidity periods (July–September)
- Hard water disrupting skin barrier
- Intense heat causing increased sweating and friction
- Gym without showering promptly afterward
- Helmets, caps, or tight chin straps causing mechanical acne
- Occupational exposure to oils, chemicals, or heavy creams
What happens when acne is delayed or mismanaged
Acne is not trivial. Left untreated or managed incorrectly — particularly with steroid creams or aggressive over-the-counter products — it can cause lasting physical and psychological consequences.
Acne scars
Deep inflammatory acne — particularly nodules and cysts — destroys collagen during the healing process, creating atrophic scars (ice-pick, boxcar, rolling) or, in keloid-prone individuals, hypertrophic raised scars. These are permanent without specific dermatological procedures. Prevention is always better — and cheaper — than scar treatment.
Post-inflammatory hyperpigmentation (PIH)
PIH is a flat dark or brownish mark caused by excess melanin production after inflammation. It is not a scar — it fades slowly with time and appropriate skin care, usually over months. Indian skin produces more melanin per inflammatory event, making PIH one of the most common complaints in Delhi dermatology practices. Picking, sun exposure, and incorrect treatments all worsen it.
Post-inflammatory erythema (PIE)
PIE is the persistent pinkish or reddish mark after acne resolves — caused by dilated blood vessels rather than pigment. It is more common in lighter skin tones and fades with time. In Indian skin, PIH is more common than PIE, but both can coexist, and they require different treatment approaches.
Keloid scarring
Some individuals — particularly those with darker Fitzpatrick V–VI skin tone or a personal or family history of keloids — develop raised, firm, occasionally itchy keloid scars from acne lesions. This must be identified before any scar procedure is attempted, as aggressive treatment of keloid-prone skin can worsen scarring significantly.
Emotional and psychological impact
Acne is consistently associated with reduced self-esteem, social withdrawal, anxiety, and depression — particularly in adolescents and young adults whose self-image is forming. These impacts are real and clinically significant. Patients who have struggled with acne for years, tried many products, and feel embarrassed or frustrated deserve honest assessment — not dismissal of the emotional dimension.
Steroid acne from OTC creams
Steroid acne is a specific pattern caused by applying potent topical corticosteroids to the face — a common and under-recognised problem in India where such creams are freely available. It presents as monomorphic papulopustular eruptions, often with skin thinning, and does not respond to standard acne treatment. It requires careful steroid withdrawal and a separate management approach.
Decision points for seeing a dermatologist
- OTC products used consistently for 6–8 weeks without improvement
- Dark marks or spots forming after each pimple
- Acne worsening around menstrual cycle (lower face, jaw, chin)
- Known PCOS or hormonal imbalance with ongoing breakouts
- Acne appearing for the first time after age 25 with no previous history
- Using steroid creams on the face — even briefly
- Feeling embarrassed, anxious, or avoiding social situations
- Painful cysts or nodules developing anywhere on face or body
- Acne worsening rapidly over 2–4 weeks
- Scarring already appearing — do not wait further
- Acne during pregnancy or if pregnancy is being planned
- Severe isotretinoin side effects if currently on it
- Acne with fever, widespread spread, or unusual distribution
- Do not start isotretinoin from a friend's prescription or online pharmacy
- Do not apply steroid creams to the face for acne — they cause a different, worse condition
- Do not request aggressive chemical peels or lasers while active acne is inflamed
- Do not start scar treatment before active acne is controlled
- Do not use multiple actives (retinoid + AHA + BHA + BPO) together without guidance
- Do not continue any treatment that is clearly worsening your acne for more than 2 weeks
A note on social-media acne "hacks"
Toothpaste, lemon juice, tea tree oil at high concentration, aspirin paste, and DIY turmeric packs may seem harmless but can damage the skin barrier, worsen PIH, and create allergic contact dermatitis on inflamed skin. What works on someone else's skin type and acne grade will not necessarily work on yours — and may set back treatment by weeks.
What DDC does not recommend online
A serious clinic should say what it will not do. These are our boundaries — not to refuse care, but because responsible practice requires them.
No diagnosis by photograph alone
DDC does not diagnose acne grade, suitability, or prescribe isotretinoin from a WhatsApp photograph or an online form. A clinical examination is required to assess lesion type, distribution, skin type, and underlying factors.
No guaranteed clearance claim
No ethical clinic can guarantee permanent acne cure. Results vary by grade, hormonal status, adherence, skin type, and individual biology. Claiming guaranteed results is not medically honest and would be misleading to patients who need realistic expectation-setting.
No self-start isotretinoin guidance
Isotretinoin requires a formal consultation, assessment of severity, contraception counselling for female patients, baseline blood investigations, consent documentation, and close monitoring. It cannot be safely started based on an article, a recommendation, or a social media post.
No peels on uncontrolled active acne
Aggressive chemical peels on actively inflamed, compromised, or recently irritated skin can worsen inflammation, cause unexpected PIH, and disrupt healing. Peel timing, depth, and formulation are medical decisions made after skin assessment — not booking choices.
No scar procedures while acne is active
Starting laser, microneedling, or other scar procedures while acne is uncontrolled is clinically incorrect. New breakouts can form in and around treated areas, worsening scarring. Active acne must be stabilised before any scar or resurfacing work begins.
No steroid cream recommendations for acne
Topical steroid creams are frequently misused in India for acne, fairness, and skin clearing. DDC does not recommend potent steroids for acne under any circumstances. Their use causes steroid acne, skin atrophy, telangiectasia, and a worsened baseline that is difficult and slow to treat.
Suitability — three honest groups
Not every patient who books a consultation should start treatment the same day. Some need workup first. A small number should defer or be referred.
What happens at the first consultation
A thorough first consultation is the most important investment in your acne journey. The plan that comes out of it is only as good as the assessment that precedes it.
Eight things the dermatologist assesses
- Lesion type: Comedonal, papulopustular, nodular, cystic, or mixed
- Distribution: Face zones, back, chest, scalp pattern — aids hormonal assessment
- GAGS severity grading: Numerical score to classify mild/moderate/severe/very severe
- Fitzpatrick skin typing: Determines PIH risk and procedure safety margins
- Existing PIH and scar assessment: Separates active acne problem from consequences
- Hormonal history: PCOS, menstrual pattern, OCP use, pregnancy status
- Product and medication audit: Identifies comedogenic products, steroid cream history, prior antibiotics
- Prior treatment history: Reasons for previous failures; antibiotic resistance risk
When additional investigations are requested
Not every patient needs blood tests. Investigations are ordered when clinical findings suggest underlying hormonal or systemic contributors:
- Serum testosterone, DHEA-S, LH/FSH ratio — when PCOS or hyperandrogenism is suspected
- Thyroid function — when adult-onset acne coincides with thyroid symptoms
- Fasting blood sugar / HbA1c — when PCOS or insulin resistance is present
- Pre-isotretinoin baseline: LFTs, lipids, beta-hCG for female patients
- Culture and sensitivity — if recurrent antibiotic treatment failure suggests resistant organisms
GAGS Acne Grading — the clinical severity framework
| GAGS Score | Grade | Clinical Picture | Typical First-Line Approach | What this means for you |
|---|---|---|---|---|
| 1 – 18 | Mild | Mostly comedones, scattered papules/pustules, minimal inflammation | Topical retinoid ± BPO; adjust skincare; patient education | Responds well with correct topicals. Maintenance reduces relapse. |
| 19 – 30 | Moderate | Widespread papules/pustules, some nodules, early PIH forming | Topical combination ± short-course oral antibiotic; PIH plan | Requires consistent 10–16 week course. PIH prevention is active priority. |
| 31 – 38 | Severe | Numerous nodules, deep lesions, risk of scarring, significant PIH | Oral antibiotic combination; isotretinoin evaluation; close review | Scar prevention is urgent. Response slower. Monthly reviews needed. |
| 39+ | Very Severe | Nodulocystic acne; sinus tracts possible; significant scarring risk | Isotretinoin after assessment and consent; hormonal pathway if indicated | Prompt treatment is medically urgent. Delay increases permanent damage. |
GAGS = Global Acne Grading System. Scoring uses a weighted formula across six facial and body zones. This table is a simplified representation for patient education. Clinical grading by examination always takes precedence.
How acne severity is graded
Every patient is scored on the Global Acne Grading System at the first visit and at every review. The score is what makes "improving" a fact rather than a feeling.
Who is a good candidate — and who needs a different pathway
Not every patient is a candidate for every treatment. The dermatologist makes this judgment after assessment. The matrix below gives you a framework — consultation confirms what applies to you.
The DDC acne care ladder — grade-matched treatment
Treatment is never a fixed package. It is matched to your acne grade, skin type, hormonal status, and prior history. The ladder below shows the general framework — your actual plan is built in the consultation.
Topical retinoid (adapalene 0.1–0.3% or tretinoin 0.025–0.05%) applied nightly. Topical benzoyl peroxide (2.5–5%) targeting C. acnes and resistance prevention. Gentle non-comedogenic cleanser and oil-free SPF30+ daily. No oral antibiotics for comedonal-only acne.
Reduction in comedone count, improvement in skin texture, reduced new lesion formation. PIH management addressed with sun protection and azelaic acid if needed.
Retinoid 2–3 nights/week long-term. BPO wash as needed. Skincare product audit maintained.
Topical combination: retinoid + BPO. If not enough: add topical clindamycin (always with BPO to prevent resistance). Consider short course oral antibiotic (doxycycline 100mg) for 8–12 weeks maximum — always combined with topical retinoid. Never oral antibiotics alone.
Significant reduction in inflammatory lesions, prevention of new nodules, stabilisation of PIH. Clinical photograph comparison at 8 weeks and 16 weeks guides escalation or de-escalation.
Retinoid and BPO continued. Antibiotic stopped after course. PIH treatment initiated after active acne controlled.
Oral antibiotic (doxycycline or lymecycline) combined with topical retinoid and BPO. Evaluate for isotretinoin if no response at 12 weeks, if noduloCystic lesions are present, if scarring is already forming, or if multiple antibiotic courses have failed. Hormonal evaluation if adult female.
Halt new scar formation. Reduce active nodular burden by 75%+. Initiate PIH pathway. Assess isotretinoin suitability if not already started.
Long-term retinoid maintenance. Post-course review at 3, 6, and 12 months. Scar/PIH procedures planned after acne is stable.
Isotretinoin after full assessment, consent, baseline investigations, and contraception counselling. Dose titrated based on weight and response. Monthly monitoring of LFTs, lipids, mood, and dryness management. For adult females: hormonal therapy (combined OCP, spironolactone) evaluated as isotretinoin alternative or adjunct where appropriate.
Sustained clearance, prevention of further scarring, preparation for post-isotretinoin maintenance. PIH and scar assessment timed to 3–6 months post-treatment.
Post-isotretinoin relapse monitoring for 12 months. Topical retinoid continuation at low frequency. Hormonal maintenance if indicated.
Hormonal acne pathway — adult women
Who qualifies
Adult females with persistent lower-face and chin acne, cyclic flares before menstruation, confirmed or suspected PCOS, elevated androgens on investigation, or failure of standard topical/antibiotic treatment.
Treatment options
Combined oral contraceptive pills (COCPs) with anti-androgenic progestogens. Spironolactone (off-label but evidence-supported). These are prescribed by the dermatologist or in coordination with a gynaecologist/endocrinologist depending on the full picture.
Antibiotic stewardship
DDC follows antibiotic stewardship principles: oral antibiotics are prescribed for the shortest effective duration, always combined with a topical retinoid and BPO, never as long-term monotherapy. This reduces antibiotic resistance risk — a growing global and local problem. Antibiotics suppress acne; they do not address the root cause.
Isotretinoin — understanding the facts
When isotretinoin is appropriate
- Severe nodulocystic acne (GAGS 31+)
- Moderate acne unresponsive to two adequate antibiotic courses
- Acne causing significant scarring despite treatment
- Severe recurring acne after prior courses of treatment
- Acne fulminans (urgent)
- Selected hormonal acne patterns where other options are exhausted
When isotretinoin is contraindicated
- Pregnancy — absolutely contraindicated (severe teratogen)
- Breastfeeding
- Uncontrolled hyperlipidaemia
- Significant liver dysfunction
- Severely uncontrolled depression or active suicidal ideation
- Vitamin A toxicity or supplementation at high dose
- Tetracyclines being taken simultaneously (raised intracranial pressure risk)
The treatment ladder — matched to your acne grade
No skipped rungs. We start at the rung your acne sits on, escalate only when the previous rung is shown to be insufficient, and never combine procedures that work against each other.
If you have this · Then we do this · Because
No two acne plans are identical. The reasoning behind each step is more important than the prescription itself. Here is how we think about your case.
If / Then / Because — how doctors think about acne cases
This section shows the clinical reasoning behind treatment decisions — not to replace a consultation, but so patients understand why different acne presentations lead to different plans.
What each option can and cannot do
Each treatment modality has a defined role in the acne care ladder. Understanding what it targets — and what it cannot achieve — prevents unrealistic expectations and incorrect self-selection.
| Modality | What it targets | Best suited for | What it cannot do | Key safety note |
|---|---|---|---|---|
| Topical retinoids (adapalene, tretinoin) |
Normalises cell turnover, reduces comedone formation, has anti-inflammatory effect at higher concentrations | All acne grades; comedonal and mild inflammatory; long-term maintenance | Does not kill bacteria; does not work quickly — needs 6–12 weeks; initial dryness and purging possible | Not to be used in pregnancy. Start slowly (every 2–3 nights) to reduce irritation on Indian skin. |
| Benzoyl peroxide | Antibacterial activity against C. acnes; prevents antibiotic resistance when combined with topical antibiotics | Inflammatory papulopustular acne; combination use with retinoid or antibiotics | Does not affect comedonal acne significantly; can bleach fabrics | Can cause dryness and barrier disruption in dark Indian skin. Use 2.5% formulation initially. |
| Topical antibiotics (clindamycin) |
Reduces C. acnes load and local inflammation | Mild-moderate inflammatory acne; always as combination, never monotherapy | Should never be used alone — resistance develops rapidly. Does not address comedones. | Always combined with BPO to reduce resistance. Duration limited. |
| Oral antibiotics (doxycycline, lymecycline) |
Systemic anti-inflammatory and antibacterial effect | Moderate-severe inflammatory acne; used with retinoid and BPO; maximum 12 weeks | Not a cure — relapse without maintenance plan. Resistance risk with long-term use. | Not in pregnancy. Take with food. Sun sensitivity. Always combined with topical retinoid. |
| Azelaic acid | Mild antibacterial, anti-comedonal, reduces PIH, safe for pregnancy (topical) | Mild acne with PIH; safe option in pregnancy under supervision; sensitive skin | Slower acting than retinoids; less effective for severe inflammatory acne alone | Well tolerated. One of the few topicals usable in pregnancy under dermatologist guidance. |
| Isotretinoin (oral) | Reduces sebum by 70–90%; normalises cell turnover; anti-inflammatory; addresses all four acne pathways | Severe/cystic acne; antibiotic-resistant acne; scarring acne; selected recalcitrant moderate acne | Not a scar treatment. Does not remove existing PIH. Relapse possible in some. | Teratogenic. Requires consent, monitoring, and contraception protocol. Not OTC or online. |
| Chemical peels (salicylic, mandelic) |
Exfoliates, reduces comedones, mild anti-inflammatory, early PIH improvement | Comedonal and mild-moderate acne; PIH after acne is controlled; selected skin types | Should not be used on inflamed/active inflammatory acne; does not replace medical treatment | Fitzpatrick IV–VI must be assessed for PIH risk before every peel session. |
| Light/laser adjuncts | May reduce sebaceous activity, C. acnes bacteria, post-acne redness, or pigment depending on device | Adjunct to medical treatment — not a primary standalone for active acne | Not a replacement for topical or oral treatment. Cannot treat hormonal acne drivers. | Must be timed after active inflammation is controlled. Skin-type assessment essential. |
Honest disclosure — every treatment has a risk profile
All effective treatments carry some degree of risk. DDC discusses these with every patient before treatment begins. This page provides a summary — your dermatologist will explain what applies to your specific situation.
Topical treatment risks
- Retinoid irritation: dryness, flaking, redness, purging (temporary — 4–6 weeks)
- BPO: dryness, bleaching of fabric, rare contact allergy
- Clindamycin alone: C. acnes resistance if used without BPO
- Azelaic acid: mild tingling initially, rare irritation
- Risk reduction: start slowly, use moisturiser, SPF daily
Oral antibiotic risks
- GI upset: take with food, avoid dairy within 2 hours of doxycycline
- Photosensitivity: increased sunburn risk — strict SPF required
- Vaginal candidiasis: probiotic and monitoring if recurring
- Antibiotic resistance: reason for short course and combination approach
- Not safe in pregnancy: doxycycline is contraindicated after first trimester
Isotretinoin — monitoring protocol
- Teratogenicity: absolute contraindication in pregnancy
- Dryness: lips, eyes, nasal passage — managed with emollients
- Liver enzymes: monitored monthly — rare elevation; usually dose-adjusted
- Triglycerides: monitored — reduce with dose reduction if elevated
- Mood: monitored at every visit; patient and family informed
- Night blindness: rare — reported if any visual changes occur
- Not taken with tetracyclines simultaneously
Chemical peel risks
- Post-peel PIH: significantly higher in Fitzpatrick IV–VI if not managed correctly
- Temporary redness, scaling, and sensitivity for 3–7 days post-peel
- Inappropriate timing: peels on inflamed acne can worsen inflammation
- Sun exposure immediately after peel must be strictly avoided
- Home peel kits without supervision carry substantial risk in Indian skin
Warning signs — when to contact DDC immediately
What you can do at home — and what makes things worse
What helps
- Gentle cleansing twice daily: A mild, non-comedogenic, pH-balanced cleanser removes excess oil and pollutants without stripping the barrier. Do not wash more than twice — over-washing signals the skin to produce more oil.
- Non-comedogenic moisturiser: Even acne-prone skin needs hydration, especially if on retinoids or BPO. A light gel-type or water-based moisturiser daily reduces irritation without clogging pores.
- SPF30+ every morning: Sun exposure worsens PIH dramatically and can increase inflammation. Non-comedogenic, matte or fluid SPF formulations exist specifically for acne-prone Indian skin. This is non-negotiable during any acne treatment.
- Shower after sweating: After gym, sports, or heavy Delhi summer commuting — change and shower promptly. Sweat-soaked clothing and prolonged contact create an environment for C. acnes proliferation.
- Non-comedogenic makeup only: If makeup is used, it must be labelled non-comedogenic or oil-free and removed thoroughly every night. Sleeping in makeup — even once — can occlude multiple pores simultaneously.
- Pillowcase hygiene: Change pillowcases every 2–3 days. Accumulated sebum, dead cells, and sweat from prior nights are reapplied to clean skin every night otherwise.
What makes acne worse
- Picking or squeezing: Spreads bacteria deeper and laterally, ruptures follicle walls, increases PIH intensity, and converts a small lesion into a larger one with higher scar risk. This is the single most damaging self-care behaviour.
- Scrubbing or physical exfoliation: Walnut scrubs, rough towel rubbing, and abrasive brushes on inflamed skin worsen barrier damage, increase PIH, and spread bacteria. Inflamed skin needs gentleness, not friction.
- Steroid creams: Potent topical steroids applied to the face cause steroid acne, skin thinning, and a rebound that is significantly worse than the original condition.
- Multiple actives simultaneously: Using retinoid + AHA + BHA + vitamin C + BPO all at once causes severe barrier disruption, irritation, and redness that is often mistaken for allergic reaction.
- Heavy hair oils on the forehead: Coconut oil, amla oil, and sarson oil — common in Indian haircare — are comedogenic. Limit contact with the hairline and forehead, particularly overnight.
- Ignoring sun protection: Skipping SPF during acne treatment — especially on retinoids, after peels, or after laser — significantly worsens PIH and delays recovery. Delhi summer UV is intense even on overcast days.
- Stopping treatment when skin seems clear: Discontinuing treatment prematurely is the leading cause of relapse. Acne responds slowly — what looks like clearance at 8 weeks often needs another 8–12 weeks of maintenance.
The skin barrier — and what acne treatment changes
Most acne advice talks about pores. But the skin is five layers, each with a job. Knowing which layer your treatment touches helps you understand why some things work and some don't.
How to make your first consultation as productive as possible
The quality of information you bring determines the quality of the plan you receive. A well-prepared patient gets a more accurate diagnosis and a better-calibrated treatment plan in the first visit.
Bring all your products
Every product you currently use on your face — cleanser, toner, serums, moisturiser, sunscreen, makeup, and any prescription creams — should either be brought in or photographed clearly. The product audit often reveals comedogenic ingredients or hidden steroid content.
Bring past prescriptions
Any previous acne treatments prescribed — including creams, gels, oral antibiotics, and any isotretinoin courses — should be documented. The names of medicines, doses, duration of use, and why they were stopped or what happened are all diagnostically important.
Take acne photographs
Photograph your acne at its worst — not on the clinic day when you may have minimised it with makeup or when a flare has partially subsided. Photographs taken in natural light, unfiltered, from multiple angles give the dermatologist important information about distribution and severity over time.
Note hormonal history
For female patients: when did acne start or worsen relative to your cycle? Does it flare before periods? Do you have PCOS, irregular cycles, or excess hair growth? Are you on an oral contraceptive pill — and when did you start or change it? Are you pregnant, planning pregnancy, or breastfeeding?
Bring blood reports if available
If you have had hormonal tests, thyroid function, fasting blood sugar, or lipid panels done recently, bring the reports. If you are already on isotretinoin from another clinic, bring your latest monitoring results.
Questions to ask your dermatologist
- What grade is my acne and what is driving it?
- Is there a hormonal component I should know about?
- What does my treatment plan look like week by week?
- What signs mean treatment is working — or not working?
- When should I expect visible improvement?
- What should I stop using immediately?
- When will we review and possibly change the plan?
Your acne care journey from consultation to maintenance
What acne treatment can — and cannot — achieve
What treatment can achieve
- Significant reduction in active lesion count within 8–16 weeks for most patients
- Prevention of new scar formation when treatment begins before damage occurs
- Reduction in PIH formation with consistent sun protection and correct topicals
- Long-term remission or sustained control in many patients
- Hormonal acne managed with appropriate therapy — cyclic flares reduced substantially
- Quality of life and confidence improvement alongside skin improvement
What treatment cannot guarantee
- Permanent guaranteed cure — acne is a chronic condition for many patients
- Elimination of all existing scars — active acne treatment does not reverse prior damage
- Instant results — the fastest genuine improvement is 6–8 weeks minimum
- Identical results to another patient's before/after — biology varies
- Zero PIH if sun protection is not followed consistently
- Sustained clearance without a maintenance plan after the initial treatment course
Six widespread acne myths — and what the evidence actually says
Acne is one of the most myth-laden conditions in dermatology. Wrong beliefs delay treatment, lead to harmful self-treatment, and create false expectations. Here is the evidence-based reality.
How real patients usually arrive — and how the assessment changes
"I've tried everything from the pharmacy."
OTC products at incorrect concentration, incorrect formulation for acne type, or applied incorrectly are the usual reasons. The clinical assessment identifies what was actually tried, whether it was adequate, and what grade and type of acne really needs to be addressed — often different from what the patient assumed.
"Antibiotics work, then it always comes back."
Antibiotic relapse almost always means maintenance therapy was not given or not followed, or that hormonal drivers were not addressed, or that antibiotic resistance has developed. The assessment evaluates resistance risk, whether retinoid maintenance was used, and whether isotretinoin evaluation is now appropriate.
"The pimples go but dark marks stay."
PIH management runs in parallel with — not after — active acne treatment. Strict sun protection, appropriate topicals (azelaic acid, niacinamide), and treatment plan calibration for Fitzpatrick skin type are addressed. The patient is told early that PIH fades over months with consistent management.
"Painful cysts are forming and I can see scars starting."
This presentation requires prompt escalation. Isotretinoin candidacy is evaluated at the same consultation. Delay is not recommended. Scar prevention is the priority — and the patient is counselled that existing scars need a separate post-acne procedure pathway, after active acne is under full control.
"I took isotretinoin before and acne came back."
Isotretinoin relapse occurs in approximately 20–30% of patients, often within 2 years. The re-assessment evaluates dose adequacy of the prior course, whether maintenance was followed, whether hormonal drivers are now evident, and whether a second course or hormonal therapy is the appropriate route forward.
"I used a fairness cream and now my skin is much worse."
Steroid acne from potent topical corticosteroids in Indian skin-lightening and fairness creams is under-recognised. The assessment identifies the steroid pattern (monomorphic eruption, skin thinning, telangiectasia) and manages withdrawal carefully — abrupt discontinuation can cause a rebound flare. This requires a specific de-steroidisation approach, not standard acne treatment.
Side-by-side comparison — what each option does, what it does not
Use this table to understand how the main acne treatment options compare. The right choice for your skin will be picked at consultation based on grade, type, history, and Fitzpatrick skin tone — not from this table alone.
| Option | Primary use | What it does well | What it does not address | Time to judge | PIH risk |
|---|---|---|---|---|---|
| Topical retinoid | Comedonal acne, maintenance | Unclogs pores, normalises cell turnover, prevents new comedones | Hormonal drivers, deep cysts | 8–12 weeks | Low if introduced gradually |
| Benzoyl peroxide | Inflammatory acne, antibiotic-resistance prevention | Kills C. acnes, reduces inflammation, prevents resistance | Sebum overproduction, scars | 4–8 weeks | Low |
| Topical antibiotic + BPO | Mild–moderate inflammatory acne | Reduces inflammation and bacterial load with stewardship safeguard | Comedones alone, severe nodules | 8–12 weeks | Low |
| Oral antibiotic | Moderate inflammatory acne, short courses | Systemic anti-inflammatory effect, fast initial response | Long-term cure — must be paired with topicals | 4–8 weeks | Low |
| Hormonal therapy | Adult female hormonal acne | Addresses androgen-driven sebum, useful in PCOS pattern | Bacterial drivers, severe cysts (alone) | 3–6 months | Low |
| Isotretinoin | Severe nodulocystic, refractory acne | Targets all four acne drivers simultaneously, often induces long remission | Cannot be used in pregnancy; requires monitoring | 4–6 months | Low if managed correctly |
| Salicylic peel | Comedonal and mixed acne adjunct | Penetrates oil-rich follicles, reduces blackheads/whiteheads | Hormonal drivers, scarring | Series of 4–6 sessions | Moderate if mistimed |
| Mandelic / lactic peel | Sensitive Indian skin, early PIH | Gentler exfoliation suited to Fitzpatrick IV–V | Severe acne, scars | Series of 4–8 sessions | Low |
| Intralesional steroid | Single painful cyst or nodule | Flattens within 24–72 hours, reduces scar risk on that lesion | Field acne — only for individual lesions | 1–3 days | Low |
| Laser / IPL adjunct | Post-acne erythema, PIH after stabilisation | Targets capillaries or pigment, smooths overall tone | Active inflammatory acne, hormonal cause | Series of 3–6 sessions | Higher — requires careful settings |
Why "cheaper or faster" can be unsafe
Patients sometimes ask for the strongest peel, the most aggressive laser, or the highest-dose oral antibiotic to "fix it faster". This rarely shortens treatment and frequently extends it. Aggressive peels on inflamed Indian skin can trigger weeks of PIH that then need separate treatment. High-dose long-course antibiotics breed resistance, fail more often, and disqualify future antibiotic options. Doubling retinoid concentration causes barrier collapse that forces a treatment pause. Conservative, calibrated, sequenced treatment delivers the best outcome in the least total time.
Why aggressive treatment may not be appropriate even if you can afford it
Cost and willingness to pay are not clinical indications. A patient ready to start isotretinoin for mild comedonal acne is being offered the wrong tool. A patient asking for fractional laser during an active cystic flare is being offered the wrong sequence. The right treatment is the one matched to acne grade, type, skin tone, history, and current barrier status — assessed by a dermatologist. Cost-led upgrades almost never improve outcomes; they shift risk profile in the wrong direction.
Devices and technology — what they do at the tissue level
Most patients ask "what does the laser actually do" or "is the peel really working". The honest answer requires a brief look at what each device does to skin tissue, what its limits are, and why operator skill changes outcomes more than the brand of the machine.
Chemical peels — controlled exfoliation
What they are: Topical acid solutions (salicylic, mandelic, lactic, glycolic, azelaic, retinoid-based) applied at calibrated concentration and contact time.
What happens at tissue level: The acid loosens bonds between dead surface cells (corneocytes) and dissolves comedonal plugs inside follicles. Salicylic acid is oil-soluble, so it penetrates the sebaceous follicle effectively — this is why it is the gold-standard peel for active acne with comedones.
Limits: Peels treat surface cells and superficial follicular plugs. They do not reach the deep dermis, do not address hormonal sebum, and do not eliminate scarring. A peel is one component of a plan — never a complete plan.
Blue-light therapy
What it is: Narrow-wavelength blue light (typically 405 to 420 nm) delivered as a cold light source for 15 to 20 minutes per session.
What happens at tissue level: Blue light excites porphyrins produced by C. acnes bacteria, generating reactive oxygen species inside the bacterial cell. This reduces bacterial load in the sebaceous follicle without thermal damage to surrounding skin.
Limits: Effective only against bacteria — does not address sebum overproduction, hormonal drivers, or inflammation that has already produced cysts. Best for mild-to-moderate inflammatory acne as an adjunct.
Intense Pulsed Light (IPL)
What it is: A broad-spectrum light source (515 to 1200 nm) filtered to target specific chromophores in skin — haemoglobin in blood vessels and melanin in pigment.
What happens at tissue level: Selectively heats post-acne erythema (red marks from inflammation) and post-inflammatory hyperpigmentation. Coagulates dilated capillaries and breaks up melanin clusters that the lymphatic system then clears.
Limits: Operator-dependent. Wrong settings on Fitzpatrick IV–V skin can cause paradoxical hyperpigmentation. Not used during active inflammatory acne.
Q-switched / pico laser for PIH
What it is: A nanosecond or picosecond pulsed laser delivering high-peak-power energy at specific wavelengths (commonly 1064 nm for deeper pigment, 532 nm for surface).
What happens at tissue level: Photoacoustic shock fragments melanosomes inside pigment cells without burning surrounding tissue. The fragments are then phagocytosed and cleared over weeks.
Limits: PIH after acne can rebound if treatment intensity is too high, especially in Fitzpatrick IV–V skin. Settings must be conservative; results are gradual; sun protection is non-negotiable between sessions.
Non-ablative resurfacing (rare adjunct)
What it is: Fractional laser delivering thousands of microscopic columns of energy through the skin while leaving surrounding tissue intact.
What happens at tissue level: Triggers dermal collagen remodelling for textural irregularities — used cautiously and only after active acne is fully controlled, primarily for early scarring concerns.
Limits: Higher PIH risk in Indian skin. Not used during active acne. Used selectively as part of a scar pathway after acne stabilisation.
Microneedling
What it is: Sterile fine-gauge needles delivering controlled micro-injuries to the skin at a calibrated depth.
What happens at tissue level: The micro-injuries trigger fibroblast activation and collagen synthesis. When combined with topical agents, the channels can briefly improve absorption.
Limits: Not a primary acne treatment. Used cautiously in post-acne scar pathways. Not used over actively inflamed acne — the needle pathway can spread bacteria and worsen lesions.
Why operator skill matters more than machine brand
Two clinics can use the same device and produce very different outcomes. The variables that matter are: correct device selection for the patient's Fitzpatrick type, calibrated energy and pulse settings, accurate spot density, real-time clinical judgment to stop or adjust mid-session, sterile technique, and patient assessment before each pass. A senior dermatologist running a mid-tier device safely will outperform an unsupervised operator running a premium device aggressively. At DDC, every device-based procedure is performed by — or directly supervised by — a qualified dermatologist. Settings are documented for every session and reviewed at the next visit.
Built-in safety controls and calibration governance
Devices are serviced and calibrated on the manufacturer's recommended cycle, with calibration logs maintained internally. Each device has documented Fitzpatrick contraindication thresholds. Test pulses are performed at the beginning of every laser session before full treatment. Cool-air or contact cooling is integrated into laser handpieces to protect the epidermis. Eye shielding is mandatory for any procedure within 10 cm of the orbital rim. These standards do not change based on schedule pressure.
What to expect — sessions, duration, downtime, and pain
Acne treatment is rarely a single procedure. Most plans combine medical therapy that runs continuously at home with periodic in-clinic procedures. Here is exactly what each visit looks like, how long it takes, what you will feel, and how soon you can return to normal life.
Consultation visit
Duration: 30 to 45 minutes for a new consultation, 15 to 20 minutes for a follow-up.
What happens: History, examination, GAGS grading, lesion mapping, Fitzpatrick assessment, product audit, photo documentation, and a written treatment plan with realistic expectations.
Pain: None.
Downtime: None. Resume work the same hour.
Comedone extraction
Duration: 20 to 30 minutes per session.
What happens: Sterile, dermatologist-supervised manual extraction of mature whiteheads and blackheads using a single-use comedone extractor after a warm compress.
Pain: Mild discomfort, controllable. No anaesthetic needed in most cases.
Downtime: Mild redness for 2 to 4 hours. Avoid makeup that day.
Salicylic acid peel (mild)
Duration: 25 to 35 minutes including prep, application, and neutralisation.
What happens: Cleansing, peel application in measured layers, timed neutralisation, soothing serum, and SPF.
Pain: Mild tingling or warmth that lasts 1 to 3 minutes.
Downtime: 24 hours of redness. Mild flaking may begin on day 2 to 3 and lasts 2 to 5 days.
Mandelic or lactic acid peel
Duration: 30 to 40 minutes.
What happens: Used for sensitive Indian skin and active comedonal acne. Gentler PIH risk profile than salicylic.
Pain: Minimal warmth.
Downtime: Same-day redness. Mild dryness for 3 to 5 days.
Intralesional injection (cyst)
Duration: 5 to 10 minutes.
What happens: Dilute corticosteroid is injected directly into a painful cyst or nodule to flatten it within 24 to 72 hours and reduce scar risk.
Pain: Brief sting at the injection point.
Downtime: None. The cyst usually softens overnight.
Laser or light adjunct
Duration: 20 to 40 minutes per zone.
What happens: Used selectively after assessment — typically blue-light, intense pulsed light, or non-ablative resurfacing for stubborn inflammatory acne or post-acne redness. Eye shielding throughout.
Pain: Snapping or warm-pinprick sensation. Topical anaesthetic available.
Downtime: Redness for 2 to 24 hours. Strict SPF 50+ for two weeks afterwards.
Patch test before any peel or laser
Every new peel and every new device is patch-tested on a small zone (typically behind the ear or on the jawline) at least 7 days before the first full-face procedure. This is non-negotiable for Fitzpatrick III–V skin. The patch test confirms tolerance and allows the dermatologist to adjust concentration, contact time, or device parameters before exposing larger skin areas.
Day-of and immediate post-procedure experience
Before you arrive
- Arrive with clean skin, no makeup, no fragrance.
- Stop active retinoids 3 to 5 days before any peel or laser, unless told otherwise.
- Avoid sun exposure or tanning for 2 weeks before laser procedures.
- Eat normally. Stay hydrated.
- Bring sunglasses if a laser session is planned.
- Disclose any new medication started since last visit.
Immediately after the procedure
- Cool compress or chilled saline if redness is significant.
- Bland moisturiser only — no actives for 24 to 72 hours.
- SPF 50+ before leaving the clinic if it is daytime.
- No hot showers, no sauna, no steam, no exercise for 24 hours.
- No makeup until next morning, longer for laser.
- Sleep on your back if possible the first night.
Restrictions in the first week
Avoid: hot yoga, gym, swimming pools, saunas and steam rooms, alcohol-based toners, scrubs, AHA/BHA products outside the prescribed plan, threading or waxing on treated zones, and direct unprotected sun exposure. International travel within 24 hours of laser is best avoided due to cabin air dryness on healing skin.
Red-flag signs that need same-day clinic contact
- Severe burning that does not settle within 30 minutes after a peel.
- Blistering, weeping, or crusting that appears within hours.
- Spreading hives or facial swelling.
- Hyperpigmentation that appears within 7 days of a procedure.
- Fever, chills, or systemic symptoms following an injection.
- Any visual disturbance after periorbital procedures.
Contact the clinic on +91 92119 48111 or WhatsApp +91 82879 00550. Out-of-hours, send a photograph and a brief note.
Typical session count and intervals
Procedure adjuncts are not stand-alone treatments. They are used in series — usually 4 to 8 sessions for peels at 2 to 4 week intervals, or 3 to 6 sessions for laser-based work at 4 to 6 week intervals — combined with continuous medical therapy at home. The interval allows the skin barrier to recover and the dermatologist to judge response before escalating intensity. Skipping intervals or compressing the schedule increases inflammation and PIH risk.
From first visit to lasting clarity
Most acne plans run 3 to 6 months of active treatment, then move to long-term maintenance. Here is what each phase actually involves.
The hormonal acne pathway in detail
Adult female acne with a hormonal driver is biologically distinct from teenage acne. It needs a different evaluation, a different first-line treatment, and a different timeline expectation. This section explains what we look for and what we do.
How we identify a hormonal pattern
A hormonal driver is suspected when the acne predominantly affects the lower face, jawline, and chin; flares cyclically in the 7 to 10 days before menstruation; persists or worsens after age 25; resists conventional topical therapy; or coexists with menstrual irregularity, hirsutism, or scalp thinning. The clinical assessment includes menstrual history, contraceptive history, weight changes, hirsutism scoring, and a focused look for the triad of polycystic ovary syndrome — irregular menses, hyperandrogenism, and metabolic features.
What blood work we order — and what we do not
Routine hormonal workup for confirmed hormonal acne typically includes: free and total testosterone, DHEA-S, sex-hormone binding globulin, fasting glucose and insulin, and prolactin if there are additional symptoms. Thyroid function is included if there is fatigue, weight change, or menstrual irregularity. Pelvic ultrasound is recommended if PCOS is clinically likely. We do not run extensive panels for patients without suggestive history — testing without indication produces incidental findings rather than answers.
Treatment options for hormonal acne
First-line topical and oral medical treatment is similar to standard acne care — retinoid plus benzoyl peroxide as foundation, with or without antibiotic. The hormonal layer adds three options. Combined oral contraceptives, when not contraindicated, can stabilise the hormonal cycle and reduce androgen-driven sebum. Spironolactone, an anti-androgen, is highly effective for adult female hormonal acne; typical doses are 50 to 100 mg daily, titrated. Metformin is occasionally used in PCOS with insulin resistance. Each option is matched to the patient's reproductive plans, blood pressure, weight, and personal preference. None is universally first-line.
Timeline expectations
Hormonal acne treatment is slower to judge. Three months is the minimum window before declaring response; six months is a more honest review point. Improvement is usually gradual rather than dramatic. The goal is not "no acne ever" — it is "predictable, controlled, scar-free acne with no severe flares". Some patients remain on a maintenance hormonal plan for years.
When we send for endocrine review
Patients with confirmed PCOS plus metabolic features, hyperandrogenism with severe hirsutism, suspected late-onset adrenal hyperplasia, or hormonal acne unresponsive to first-line therapy are referred to a gynaecological endocrinologist. Acne management continues at DDC; the endocrine team manages the systemic condition. This collaborative model produces better outcomes than either specialty working alone.
Isotretinoin, explained honestly
Isotretinoin attracts more fear and more misinformation than any other acne medication. Most of the fear comes from genuine risks that need monitoring rather than mythical risks that do not exist. This section covers what is real, what is monitored, and what is not a concern.
Who is a candidate
Severe nodulocystic acne with scar formation, refractory acne unresponsive to 6+ months of optimised topical and oral therapy, severe acne with significant psychological impact, or acne with a strong sebaceous component that has resisted hormonal therapy in adults. Not every severe acne case starts here — but every case meeting the above criteria is properly evaluated.
Pre-treatment workup
Baseline blood work includes full lipid profile (fasting), liver function tests, complete blood count, and pregnancy test for women of reproductive age. Two negative pregnancy tests one month apart, plus two reliable contraceptive methods, are required before starting in any patient capable of pregnancy. Mood screening is performed at baseline and at every monthly visit. The patient and the dermatologist sign a formal counselling document covering the full risk profile.
Monitoring during treatment
Lipids and liver function are repeated at month 1 and then every 1 to 2 months depending on baseline values. Pregnancy testing for relevant patients is performed monthly. Mood is reviewed at every visit; any change in mood, sleep, anhedonia, or thoughts of self-harm is taken seriously and triggers immediate treatment review. Visual symptoms, persistent headache, severe abdominal pain, jaundice, severe joint pain, or persistent severe muscle pain are urgent contact triggers.
Real risks, monitored
Dryness — universal, manageable with bland moisturiser, eye drops, lip balm, intranasal saline. Lipid elevation — common, usually mild, rarely requires dose adjustment. Liver enzyme elevation — uncommon, usually mild, monitored. Mood changes — occur in a minority of patients, fully reversible on stopping. Pregnancy — severe birth defects; pregnancy must be prevented absolutely. Inflammatory bowel disease association — debated in the literature, monitored if any GI history.
Risks often overstated
Permanent organ damage — not supported by long-term safety data when monitored correctly. Permanent infertility — not supported by data. "Skin will become permanently dependent on isotretinoin" — false; skin recovers fully. Cancer risk — not supported by data. Many of the most-shared online claims about isotretinoin do not match what controlled studies show. We discuss specific concerns at consultation rather than treating them as universal facts.
What success looks like
The realistic outcome of a complete cumulative-dose course is long-term remission in most patients — meaning years without significant relapse. A subset of patients (around 15 to 25%) require a second course at some point. A small group does not respond fully, in which case treatment is reviewed for an alternative pathway. The question "is isotretinoin safe" is the wrong one. The right question is "is isotretinoin safe for me, in my specific situation, with monitoring" — and that is what the consultation answers.
How we use antibiotics — and why we limit them
Antibiotics work for inflammatory acne. They also cause the most preventable problem in long-term acne management: bacterial resistance, treatment failure on relapse, and disqualification of future antibiotic options. Stewardship is not optional. It is a clinical standard.
At DDC, oral antibiotic courses for acne are capped at 12 weeks except in unusual circumstances. Every oral antibiotic course is paired with topical benzoyl peroxide, which prevents resistance development without itself inducing resistance. Topical antibiotics are not used as monotherapy — only in fixed-combination products with benzoyl peroxide or as a short-term add-on. Repeat antibiotic courses for the same patient trigger a treatment review rather than another prescription.
The reasoning is biological rather than philosophical. C. acnes develops antibiotic resistance over time. A patient who has had three or four antibiotic courses over several years often presents with acne that no longer responds — and now also will not respond if a future systemic antibiotic is needed for a different infection. Limiting acne antibiotic exposure protects both the immediate treatment outcome and the patient's long-term antibiotic options. Patients who arrive having taken multiple prior courses are evaluated for hormonal therapy, isotretinoin, or non-antibiotic combination plans rather than another round of antibiotics.
How we manage post-acne dark marks
Post-inflammatory hyperpigmentation is the second wave of acne suffering, especially in Indian skin. Treating PIH while acne is still active makes both worse. Treating it correctly, in sequence, gives clean results. Here is the pathway.
Stage 1 — Active acne control (months 1 to 3)
The single most effective PIH prevention is controlling the inflammatory acne that is producing it. Daily SPF 50+ broad-spectrum sunscreen is non-negotiable from day one — sun exposure deepens existing PIH and provokes new pigment in healing skin. Topical retinoid is foundational: it speeds turnover of pigmented surface cells while also addressing the active acne. No procedural PIH treatment in this phase.
Stage 2 — PIH-targeted topicals (months 3 to 6, after acne stabilises)
Once active acne has stabilised — defined as no new inflammatory lesions for 4 weeks — PIH-targeted topicals are introduced. Tranexamic acid topical, niacinamide, alpha arbutin, kojic acid, and azelaic acid are common options, used singly or in low-strength combinations. Hydroquinone is reserved for moderate to severe PIH, used at 2 to 4% concentration in a structured cycle (typically 8 to 12 weeks on, then off) under supervision. Daily sunscreen continues to be the most important variable.
Stage 3 — Procedure adjuncts (month 6 onwards, only if needed)
If topical-stage results plateau and significant PIH remains after 4 to 6 months, procedure adjuncts may be considered — at consultation, not by self-selection. Options include: serial mandelic or lactic peels for surface PIH, low-fluence Q-switched 1064 nm laser for deeper pigment in Fitzpatrick IV–V, picosecond laser for resistant pigment, or microneedling with tranexamic acid in selected cases. Settings are conservative; intervals are generous (4 to 6 weeks); SPF compliance between sessions is verified.
What patients usually want — and what is realistic
Most patients want PIH gone in weeks. Realistic timelines: surface PIH responds over 3 to 6 months with topicals; deeper PIH and PIH on Fitzpatrick IV–V skin can take 6 to 12 months for substantial improvement. Aggressive shortcuts produce rebound pigment that lasts longer than the original PIH. Slow, layered, sequenced treatment delivers the best long-term outcome.
Acne in Delhi — the local layer most pages ignore
Treatment plans written for European or American skin do not transfer cleanly to Indian patients. The skin tone is different, the climate is different, and the cultural patterns of skincare, diet, and grooming are different. Here is what changes.
Monsoon and humidity
The Delhi monsoon — late June to early September — adds two acne triggers: skin occlusion from prolonged humidity and increased sweat-and-friction interactions. Sebum mixes with humid air and trapped sweat, producing fungal-acne overlap and bacterial bloom. Treatment plans started in monsoon months use lighter, less occlusive vehicles. Heavy creams that would be tolerated in winter cause breakouts in monsoon. Pre-monsoon patients are warned about the seasonal tilt and given a lighter regimen for the rainy months.
Winter dryness and central heating
December and January in Delhi bring low humidity and aggressive central heating. The skin barrier weakens, especially on retinoid users. Patients who tolerated their regimen all summer present in January with redness, sensitivity, and a sudden flare. The plan adjusts: bland moisturiser before retinoid (the "moisturiser sandwich"), reduced retinoid frequency, and fragrance-free cleansers. Patients are warned at the December visit so the adjustment is proactive rather than reactive.
Air pollution exposure
Delhi's PM2.5 and PM10 levels in October to February are among the worst in any major Indian city. Particulate exposure correlates with increased oxidative stress in skin, worsened pigmentation, and aggravation of inflammatory acne. Practical adjustments: thorough double cleansing on high-AQI days, antioxidant serum (vitamin C, niacinamide) as a daily morning step, mineral SPF that also acts as a particle barrier, and avoiding outdoor exercise during peak pollution hours.
Holi, Diwali, and festival-week skin
Three weeks each year produce predictable acne flares: Holi (colour exposure on broken skin), Diwali (smoke, pollution, late nights, rich food), and the wedding season (heavy makeup applied to inflamed skin, plus stress). Patients with active treatment plans are given specific pre- and post-festival adjustments — pause retinoids 3 days before Holi, double-cleanse the same evening, no procedures the week before or after major festivals, and a written plan for wedding-week skincare.
Cultural skincare patterns to discuss honestly
Many Indian patients arrive having tried: ubtan, multani mitti, turmeric paste, sandalwood, lemon juice as a "natural lightener", coconut oil as a moisturiser on acne-prone skin, ghee massage. Most are neutral. A few are actively harmful — lemon juice causes phototoxic pigmentation, comedogenic oils worsen acne, multani mitti can dehydrate the barrier when overused. We do not lecture; we just clarify what is helping, what is neutral, and what is making things worse for that specific patient's skin.
Diet, dairy, and the Indian context
Indian dietary patterns include daily dairy (milk in chai, paneer, curd), refined carbohydrates (roti from refined flour, white rice), and traditional sweets at family events. The high-glycaemic and dairy patterns can aggravate acne in susceptible individuals. We discuss this honestly — not as a "diet causes acne" claim but as one variable that may shift outcomes for some patients. A trial of reduced dairy and lower-glycaemic eating for 8 weeks is reasonable; aggressive elimination diets are not.
Gym, helmet, and mask acne
Sports acne from sweat and friction (mechanical "acne mechanica"), helmet acne in two-wheeler users, and prolonged-mask acne are common Delhi-specific patterns. The fix is not stopping the activity — it is shower-after-sweat protocol, freshly washed cotton liners under helmets, and changing masks every 4 hours rather than wearing the same one all day. Most cases resolve within 6 weeks of the protocol change without medication escalation.
Sun exposure patterns
Indian patients often think sun protection matters less because of darker skin. Biologically, melanin gives partial UV protection, but it does not protect against pigment changes — and PIH after acne is far worse on Fitzpatrick IV–V than on lighter skin. Daily broad-spectrum SPF 50+ is the single most important non-prescription step in any acne plan, year round, indoor and outdoor (UV penetrates window glass; HEV light from screens contributes to pigmentation).
Practical patient resources — print and bring to your consultation
These three short documents help you arrive prepared, follow the plan correctly afterwards, and ask the right questions at the consultation. Each is a single page, designed to print at home or save to your phone.
Pre-treatment checklist
What to stop, when to stop it, what to bring, what to disclose. Includes the medication wash-out window for retinoids, antibiotics, and isotretinoin. Pregnancy disclosure prompt. Sun-exposure log. Medication list template.
Coming soonPost-treatment care checklist
What to apply, what to avoid, when to return to gym, swimming, makeup, and sun exposure. Red-flag symptom list. WhatsApp number for out-of-hours photo review. Day-by-day expected timeline for redness, peeling, and full settling.
Coming soonConsultation questions to ask
The seventeen questions every acne patient should ask during the first consultation — and the dermatologist's expected style of answer. Includes the questions most patients forget: "what could go wrong", "what is plan B if this fails", "when do we re-evaluate", "what should I never use".
Coming soonNote: Download links are placeholders during page setup. The signed PDFs will be uploaded to /public/downloads/ by the clinic team and the URLs above will activate at that point. The content of each PDF is already written and reviewed.
The questions and feelings most people don't say out loud
Acne carries a load that goes beyond the skin. Many patients walk into a consultation having already fought a private battle of social-media advice, family pressure, embarrassment, and self-blame. Naming these openly shifts the consultation from sales conversation to genuine medical care.
Fear before treatment
Many patients arrive afraid of three things in particular — "isotretinoin will damage my organs", "the laser will burn my skin", and "the doctor will judge how I have neglected my skin". None of these fears are unreasonable, and pretending they don't exist makes consultations worse. We discuss them directly. Isotretinoin is not toxic when monitored. Lasers are not a guess — settings are calibrated to your skin type. And no patient is judged for what they tried before arriving here.
Why patients delay too long
The most common reason patients arrive after a year of cystic acne is not money or access — it is hope that "it will sort itself out". Mild acne often does. Cystic acne with deep nodules rarely does, and every month of delay raises scar risk. If you have been waiting more than three months for cystic acne to resolve on its own, the wait itself is now causing damage that will need separate treatment later.
Embarrassment around adult acne
Adult acne, especially in women in their thirties and forties, carries an embarrassment that teenage acne does not. Patients describe feeling "I should be past this" or "it must be something I am doing wrong". Adult acne is medically common, biologically driven by hormones in many cases, and not a personal failure. It is also more responsive to treatment when the hormonal driver is identified — which is why the consultation asks the questions it does.
Anxiety about pain, downtime, judgment
Three common worries: "will the procedure hurt", "how many days will my face look bad", and "will the receptionist see how my skin really looks". Honest answers: most acne procedures cause mild discomfort and brief redness rather than significant pain. Visible peeling lasts 2 to 5 days for most peels, longer for stronger procedures. Reception staff are not part of clinical assessment; only the dermatologist examines the skin in detail.
Frustration after failed treatments elsewhere
Patients who have tried two or three previous courses of treatment without sustained results often arrive defensive — expecting to be told they did something wrong, or that their case is hopeless. Neither is usually true. Most "failed" treatment elsewhere reflects a wrong grade match, a missing hormonal evaluation, an antibiotic course without maintenance, or a peel sequence that started too aggressively. A clean re-evaluation with full prior history is usually enough to identify what to do differently.
Wedding and event-visibility pressure
The pre-wedding patient is an entire category by themselves. Six months out, every cyst feels catastrophic. The consultation has to manage two timelines simultaneously — the medical one (8 to 12 weeks for most plans) and the emotional one (the photograph that will exist for fifty years). Honest planning starts at least 4 to 6 months before the event. Late arrivals get conservative options designed not to risk an unhealed reaction in photographs.
Confusion between similar concerns
Patients often arrive saying "I have acne scars" when they have post-inflammatory hyperpigmentation, or "I have hormonal acne" when they have stress-driven flares. The names sound similar; the treatments are very different. Part of the consultation is gently re-naming what is actually present, because choosing the wrong page or the wrong treatment based on the wrong name is one of the most common reasons people feel "nothing has worked".
"Doing nothing now" can be the right choice
For some patients — pregnancy, recent oral isotretinoin completion, very recent severe sun damage, current barrier collapse — the correct medical answer is "wait three to six months before any procedure". This is rarely what the patient wants to hear. It is sometimes the most protective recommendation a dermatologist can give. Doing the wrong thing now adds problems that will need their own treatment later. Doing nothing for a defined window is not neglect; it is sequencing.
What to tell the doctor honestly
The single most useful thing a patient can do is full disclosure. Steroid creams used for "fairness". Friend's prescription tablets borrowed during a flare. Skin-lightening injections from a salon. Aggressive scrubs from social media. None of these change the dermatologist's view of you — they change the treatment plan substantially. Withholding history almost always leads to a wrong plan that fails. Honesty in the first consultation is the single biggest predictor of good results.
Acknowledging social-media misinformation
Most patients arrive having watched at least three influencer videos, read at least one viral thread, and tried at least one product the algorithm suggested. The information landscape around acne is genuinely confusing — much of what trends online is wrong, some of it is dangerous, and a small amount is reasonable but applied to the wrong skin type. The consultation is a safe space to bring all of this. Show us the products you bought, the routines you saw, the advice you followed — we will not roll our eyes. We will simply tell you what is helping, what is neutral, and what is making things worse.
How DDC is run behind the scenes
A treatment is only as good as the systems supporting it. Below is the operational layer most patients never see — but it is what separates supervised dermatology care from cosmetic-room aesthetics.
Clinical photography standards
Every patient on a treatment plan has standardised baseline photographs at the first visit: front, oblique, and lateral views, neutral expression, no makeup, identical natural-light positioning. Repeat photographs are taken at week 4, week 8, week 12, and at major plan reviews. The same camera, distance, lighting, and angle are used each time so that change can be judged objectively rather than by impression. Photographs are stored only in the patient's clinical file with consent.
Documentation and audit trail
Every consultation generates a written clinical note with: GAGS score, lesion map, current treatment list, prescription rationale, patient counselling points, and the next review date. Each procedure visit records device used, settings, duration, areas treated, and any reactions. This documentation enables continuity of care if the patient is later seen by a different DDC dermatologist, supports clinical decision-making at follow-ups, and is available to the patient on request.
Multi-doctor review for difficult cases
Cases that have failed three or more prior treatment lines, cases involving isotretinoin in patients under 16 or over 45, cases combining acne with significant pigmentation or scarring, and cases with unusual presentation are presented at an internal clinical review with a second qualified dermatologist before treatment escalation. This safeguards against single-clinician anchoring and improves outcomes for the most complex patients.
Procedure-room safety summary
Single-use comedone extractors, single-use needles, sterile peel-application brushes per patient, EN-standard medical-grade gloves, alcohol-based skin preparation before any breach of skin, sharps disposal per Indian Bio-Medical Waste Rules, weekly autoclave-cycle verification logs, and quarterly external infection-control audit. Devices are calibrated on the manufacturer's recommended schedule, and laser handpieces are tested with a power meter before any session involving a Fitzpatrick IV–V patient.
Staff role map
Clinical decisions — diagnosis, prescription, procedure planning, escalation — are made only by qualified dermatologists registered with the Delhi Medical Council or equivalent state council. Trained clinical assistants prepare the patient, take baseline measurements and photographs, and assist during procedures under direct dermatologist supervision. Reception staff handle scheduling and basic queries but never give clinical advice or recommend treatments. This separation is enforced operationally.
Branch consistency
The East of Kailash, Gurgaon, and Noida branches use the same clinical protocols, the same prescription formulary, the same device selection criteria, and the same patient documentation standards. A patient seen at Gurgaon for the initial consultation can continue treatment at East of Kailash without restarting evaluation. Photo records, clinical notes, and treatment plans transfer with the patient. The treating dermatologist may differ; the standard does not.
Protocol review and update governance
Clinical protocols are reviewed annually against current dermatology guidelines from the American Academy of Dermatology, European Academy, and Indian Association of Dermatologists. Updates are documented internally with the date of revision and the reviewer. Patient-facing pages are reviewed on the same annual cycle — every page on this site shows a "last reviewed" and "next review due" date for transparency.
Re-entry after interrupted treatment
Patients who pause treatment for any reason — pregnancy, illness, financial reasons, travel, or simply lapsed engagement — are not penalised on return. The dermatologist re-evaluates the current state, reviews what was achieved during the previous treatment phase, identifies what changed during the gap, and proposes a fresh plan rather than resuming where things stopped. Re-entry is treated as a new consultation.
Treatment standardisation statement
Despite standardised protocols, no two patients receive an identical plan. Standardisation refers to the framework — how decisions are made, what gets documented, what safety thresholds apply — not to the prescription itself. Acne grade, skin tone, history, hormonal status, and goals are the variables that shape each individual plan within the standard framework.
What before-and-after photos can prove — and what they cannot
Photographs and testimonials are useful supportive evidence. They are not predictive of your outcome. This section explains the distinction so you can read clinic photographs critically — including ours.
What a single before-and-after pair proves
It proves that a particular patient, on a particular plan, with a particular skin type, hormonal status, age, and adherence pattern, achieved that specific outcome. It does not prove the same plan will produce the same outcome on different skin. Acne is multifactorial; predictors of response in another patient include their grade, type, hormonal driver, prior treatment history, Fitzpatrick skin tone, and lifestyle factors. None of these are visible in a single photograph pair.
What an aggregated set of photographs can suggest
A larger photograph set covering a range of grades, skin types, and treatment combinations can suggest the realistic distribution of outcomes — best-case, average-case, partial-case, and non-responder. This is more honest than showcasing only best-case results. When DDC publishes before-and-after evidence in the future, it will be presented as a distribution rather than a highlight reel.
How DDC governs clinical photographs
Patient photographs are taken in a controlled clinical setting using consistent lighting, distance, and angle so that change is real, not a lighting effect. They are stored only in the clinical record. Public use requires separate written consent. Identifying features — eyes, distinctive marks — are obscured unless the patient has specifically consented to identifiable use. No photograph is filtered, smoothed, or otherwise edited beyond cropping and standard exposure normalisation.
How testimonials are used here
Patient quotes, when used, describe their personal experience of the consultation, the treatment, and the clinic. They do not function as efficacy claims. Phrases like "this treatment cured my acne" or "guaranteed me clear skin" are not how DDC presents testimonials, even when individual patients describe their experience in those terms. We edit testimonials only to remove identifying details and overclaiming language; the underlying patient experience is not altered.
Read photographs and testimonials as supportive context. The decisive evidence for whether a treatment fits you is the consultation — your specific assessment, not someone else's photograph.
Terms used on this page — plain definitions
If you have read a term here that you were not sure about, look it up below. The advanced medical layer at the bottom of the page contains additional clinical detail for patients and clinicians who want it.
Acne vulgaris
The medical name for common acne — a chronic inflammatory condition of the pilosebaceous unit. ICD-10 code L70. Distinct from acne rosacea, perioral dermatitis, or folliculitis.
Antibiotic stewardship
The clinical practice of using antibiotics for the shortest effective duration, paired with non-antibiotic maintenance therapy, to limit resistance development. At DDC, oral antibiotic courses for acne rarely exceed 12 weeks.
Azelaic acid
A topical agent with anti-inflammatory and mild antibacterial properties. Useful in pregnancy because it has a favourable safety profile when other topicals are contraindicated.
Benzoyl peroxide (BPO)
A topical bactericidal agent that kills C. acnes without inducing resistance. Used continuously alongside antibiotics to limit resistance and as ongoing maintenance after antibiotics stop.
C. acnes
Cutibacterium acnes (formerly Propionibacterium acnes). A bacterium that lives normally on skin and proliferates inside blocked sebaceous follicles, contributing to inflammatory acne.
Comedone
A blocked hair follicle. Open comedones present as blackheads (pigment is oxidised sebum, not dirt). Closed comedones present as whiteheads.
Cyst (acne)
A deep, painful, fluid- or pus-filled lesion below the skin surface. Cystic acne is the highest scar risk subtype and warrants prompt dermatologist evaluation.
Fitzpatrick skin type
A six-point classification of skin tone and sun reactivity. Indian skin is typically Fitzpatrick III to V. Higher Fitzpatrick types have higher post-inflammatory pigmentation risk and require more conservative procedure settings.
GAGS
Global Acne Grading System. A scoring tool that assesses six facial zones plus chest and back. Total score classifies acne as mild (1–18), moderate (19–30), severe (31–38), or very severe (39+).
Hormonal acne
An acne pattern driven primarily by androgen-related sebum production. Typical presentation: adult female, lower face, jawline, chin, with cyclic flares around menstruation. PCOS is a common driver.
Isotretinoin
An oral retinoid medication used for severe nodulocystic or refractory acne. Targets all four acne drivers simultaneously. Highly effective, also highly teratogenic — strict pregnancy prevention is mandatory.
Maintenance therapy
The continuation of low-intensity topical treatment (typically retinoid plus or minus BPO) after acne has cleared, to reduce relapse rate. Maintenance is usually long-term — months to years.
Nodule
A firm, deep, inflamed lesion below the skin surface, larger than a papule. Painful, slow to resolve, scar-prone.
Papule
A small, raised, inflamed lesion without visible pus. The classic "red bump" of inflammatory acne.
PCOS
Polycystic ovary syndrome. A common endocrine condition with menstrual irregularity, elevated androgens, and metabolic features. A frequent driver of adult female acne.
PIE — Post-inflammatory erythema
Persistent redness left after an inflammatory acne lesion resolves. Different from PIH — PIE is vascular, not pigmentary. Settles slowly on its own; can be supported with vascular-targeted laser if needed.
PIH — Post-inflammatory hyperpigmentation
Brown or grey discolouration left after inflammation resolves. Common in Fitzpatrick III–V skin. Flat, not a scar. Settles over months to years; can be supported with topicals and selected procedures after acne is controlled.
Pilosebaceous unit
The hair follicle plus its sebaceous (oil) gland. Acne is fundamentally a disorder of this unit.
Pustule
A small lesion with visible pus at the surface. An inflamed papule that has progressed.
Retinoid
A vitamin-A-derived agent that normalises skin cell turnover and unclogs pores. Topical retinoids include adapalene, tretinoin, and tazarotene. Oral form is isotretinoin.
Retinoid purging
A temporary increase in breakouts in the first 3 to 6 weeks of starting a retinoid, due to accelerated turnover of pre-existing follicular plugs. Not an allergic reaction; settles within 6 weeks.
Sebum
The oily secretion of the sebaceous gland. Excess sebum is one of four primary acne drivers. Driven primarily by androgens.
Spironolactone
An anti-androgen medication used in adult female hormonal acne to reduce androgen-driven sebum. Not used during pregnancy.
Steroid acne
Acne triggered or worsened by topical or systemic corticosteroid use. Common iatrogenic driver, often from over-the-counter "fairness creams" containing steroids. Resolves slowly after stopping the trigger.
Teratogenic
Capable of causing birth defects. Isotretinoin is severely teratogenic — pregnancy prevention is non-negotiable during and for at least one month after treatment.
Topical
Applied to the skin surface (cream, gel, lotion, foam). Distinguished from systemic — taken by mouth or injection.
Tretinoin
A first-generation topical retinoid. Highly effective; can cause irritation in sensitive skin. Used at low concentration, gradually titrated.
Whitehead
A closed comedone — a blocked follicle that has not opened to the surface. Appears as a small flesh-coloured or white bump.
Advanced clinical layer (optional reading)
Open advanced medical detail (clinicians and curious patients)
Pathophysiology summary
Acne is initiated by androgen-stimulated sebaceous hyperplasia and altered sebum lipid composition, particularly increased squalene oxidation products. Follicular hyperkeratinisation produces the microcomedone — the precursor lesion — which can persist asymptomatically for weeks. C. acnes biofilm formation inside the comedone activates innate immunity through Toll-like receptor 2, triggering interleukin-1α, interleukin-8, and TNF-α production. The resulting neutrophilic infiltrate produces visible inflammatory lesions. Indian skin's higher melanocyte activity adds a post-inflammatory pigmentary layer that often outlasts the inflammatory event itself.
Treatment selection logic — clinician summary
Mild acne (GAGS 1–18, predominantly comedonal): topical retinoid as foundation, with or without benzoyl peroxide depending on inflammatory component. Moderate (GAGS 19–30): combination topical retinoid plus benzoyl peroxide plus topical or oral antibiotic depending on extent. Severe (GAGS 31–38): consider oral antibiotic plus full topical regimen, hormonal therapy in adult females, isotretinoin for refractory cases. Very severe (GAGS 39+) or cystic with scar formation: isotretinoin evaluation, with intralesional steroid for individual painful cysts and proper baseline workup.
Indian-skin specific considerations
Salicylic acid penetrates oil follicles and is generally well tolerated, but concentration above 20% raises PIH risk in Fitzpatrick V. Mandelic and lactic acid are gentler alternatives. Q-switched 1064 nm at conservative fluence is preferred over 532 nm for PIH in darker skin. Fractional non-ablative resurfacing settings used in lighter populations can produce paradoxical hyperpigmentation in Fitzpatrick IV–V; conservative settings and longer intervals are essential. Strict daily SPF 50+ broad-spectrum is non-negotiable throughout treatment in Indian patients.
Antibiotic stewardship principles
Limit oral antibiotic monotherapy. Always pair with benzoyl peroxide to limit resistance development. Cap course at 12 weeks. Avoid repeated short courses. Consider hormonal therapy or isotretinoin earlier rather than recycling antibiotics. Reserve clindamycin topical use to combination products with BPO. Document each course in the patient's record so duration and indication are tracked.
Quick-reference acne glossary — 30 additional terms
Compact definitions of acne and dermatology terms used across this page and in clinical practice. These complement the expandable definitions above.
- Adapalene
- A third-generation topical retinoid commonly used in mild to moderate acne. Generally better tolerated than tretinoin in Indian skin, with lower irritation potential.
- Androgens
- The group of hormones (including testosterone and dihydrotestosterone) that stimulate sebaceous-gland activity. Elevated or hypersensitive androgen signalling is a key driver of hormonal acne.
- Blackhead
- Lay term for an open comedone — an open follicle plugged with sebum and dead cells. The dark colour is oxidised lipid, not dirt, and is not removable by scrubbing.
- Boxcar scar
- An atrophic acne scar with sharp vertical edges and a flat base, typically 1.5–4 mm wide. Responds best to fractional resurfacing, TCA CROSS, or punch techniques after active acne is controlled.
- Clindamycin (topical)
- A topical antibiotic used in inflammatory acne. Always paired with benzoyl peroxide to limit resistance development; avoided as monotherapy.
- Combined oral contraceptive (COC)
- Oestrogen-plus-progestin pill. Selected formulations with anti-androgenic progestins may help female hormonal acne. Decision is multidisciplinary; not first-line for acne in every patient.
- Cumulative isotretinoin dose
- The total milligrams per kilogram of isotretinoin received during a treatment course. Many regimens target a cumulative dose in the 120–150 mg/kg range to reduce relapse risk; the exact target is individualised.
- Dapsone (topical)
- A topical anti-inflammatory and antibacterial agent used in selected inflammatory acne, particularly in adult women. Tolerance and pricing vary; not universally first-line.
- Doxycycline
- An oral tetracycline antibiotic commonly used for moderate inflammatory acne. Photosensitising; daily SPF is mandatory. Contraindicated in pregnancy and in children under 8.
- Fractional CO₂ laser
- An ablative resurfacing laser used for atrophic acne scars. In Fitzpatrick III–V skin, conservative settings, longer intervals, and strict aftercare reduce post-inflammatory pigmentation risk.
- High-glycaemic-load diet
- An eating pattern dominated by refined carbohydrates and sugars that raise insulin and IGF-1, both of which can amplify androgen-driven sebum production and aggravate acne in susceptible patients.
- Hyperandrogenism
- A clinical or biochemical state of elevated androgen activity. May present with acne, hirsutism, scalp thinning, and menstrual irregularity. Investigated when adult female acne is severe, late-onset, or treatment-resistant.
- Ice-pick scar
- A narrow, deep, V-shaped atrophic scar (typically under 2 mm wide) extending into the dermis. Best addressed by TCA CROSS, punch techniques, or selective fractional resurfacing rather than superficial peels.
- Keloid
- A pathological raised scar that grows beyond the boundary of the original wound. More common in darker skin types and on the chest, shoulders, and jawline. Procedure planning around acne in keloid-prone patients is conservative.
- Maskne
- Acne or acneiform breakouts in mask-contact zones (chin, perioral area, jawline) caused by heat, humidity, friction, and occlusion. Settles with mask hygiene, lighter routines, and standard acne treatment when persistent.
- Microcomedone
- The earliest, microscopic, clinically invisible stage of follicular plugging. Topical retinoids act primarily at this stage, which is why they continue working even when no lesions are visible.
- Microneedling
- A controlled-injury procedure using fine needles to induce collagen remodelling. Used for atrophic acne scars after acne is controlled. Not recommended over actively inflamed lesions.
- Niacinamide
- Vitamin B3 used topically as an anti-inflammatory and barrier-supportive ingredient. Generally well tolerated in Indian skin and useful as a supportive adjunct, not a primary acne treatment.
- Non-comedogenic
- A product-label claim indicating that a formulation has been tested or formulated to minimise follicular plugging. Useful but not regulated; a non-comedogenic label does not guarantee zero comedone risk in every patient.
- Open comedone
- The medical term for a blackhead — a dilated follicle with a visible plug at the surface that has oxidised on contact with air.
- Photodynamic therapy (PDT)
- A light-based treatment that activates a topical photosensitiser to reduce sebaceous gland activity. A specialised adjunct for selected resistant inflammatory acne, not a routine first-line option.
- Pomade acne
- A comedonal acne pattern triggered by occlusive hair products (oils, gels, waxes) along the hairline, temples, and forehead. Resolves when the offending product is identified and removed.
- Rolling scar
- A broad, shallow, undulating atrophic scar caused by tethering of dermal tissue to deeper structures. Subcision plus fractional resurfacing is a common combined approach after acne is stable.
- Salicylic acid
- A beta-hydroxy acid that penetrates sebum-filled follicles. Used in cleansers, leave-on products, and superficial peels. Concentrations above 20 % raise PIH risk in darker skin and require dermatologist supervision.
- Sebaceous gland
- The oil-producing gland attached to a hair follicle. Sebum overproduction by these glands, under androgen stimulation, is one of four core acne drivers.
- Steroid-induced rosacea
- A facial inflammatory pattern caused by prolonged use of topical corticosteroids — including over-the-counter "fairness" or combination creams. Features include persistent erythema, telangiectasia, and monomorphic pustular acne; supervised tapering is essential.
- Subcision
- A minor in-clinic procedure using a fine needle or cannula to release fibrous bands tethering rolling scars. Often combined with microneedling, fractional resurfacing, or fillers in a planned scar program.
- TCA CROSS
- Chemical Reconstruction of Skin Scars — focal high-concentration trichloroacetic acid applied into the base of ice-pick scars to stimulate collagen remodelling. A precision technique with PIH risk in darker skin if mis-dosed.
- Telangiectasia
- Small, persistently dilated blood vessels visible on the skin surface. May appear after long-term topical steroid use, sun damage, or rosacea overlap. Specific vascular lasers, not acne treatments, address them.
- Truncal acne
- Acne involving the chest, back, shoulders, or upper arms. Biologically the same disease as facial acne but aggravated by sweat, friction, and occlusive clothing; often needs different topical vehicles and broader-coverage strategies.
Starting price — with full terms
- Dermatologist assessment and diagnosis
- GAGS severity grading
- Written personalised treatment plan
- Product and trigger audit
- Follow-up review pathway
What affects the final cost
- Acne grade: Mild acne may need topicals only. Severe acne may need oral medicines, investigations, and closer monitoring.
- Medicines prescribed: Topical vs oral; branded vs generic; combination plans vary in cost.
- Investigations: Hormonal panels, lipid panels, LFTs for isotretinoin monitoring add to cost and are priced separately.
- Procedure adjuncts: Chemical peels, light therapy, or other adjuncts are priced per session after assessment confirms suitability.
- Number of follow-up visits: Mild acne may need 2–3 visits. Severe or isotretinoin cases require monthly review visits.
- Combination plan: Active acne + PIH + scar prevention may involve separate pathways and costs.
What is not promised
- No fixed final package price can be given without a dermatologist assessment — acne treatment is grade-dependent, not package-dependent.
- No "full clearance" packages with guaranteed results are offered — this would not be medically honest.
- Cost should not drive the choice between a safe conservative plan and an aggressive shortcut.
*Starting from ₹1,999 applies to dermatologist consultation. Final cost depends on grade, treatment plan, medicines, investigations, procedures, sessions, and combination plan. Prices are indicative and confirmed at consultation. GST applicable as per prevailing rates.
Planning acne treatment around important events
One of the most common patient questions is how to time treatment for weddings, photoshoots, or events. The honest answer is: the further away the event, the more we can do safely.
Event in 7 days or less
Medical treatment cannot make a meaningful difference in 7 days. Aggressive last-minute treatment — peels, extractions, or high-strength actives — can cause redness, dryness, or reactions that make skin worse before an event. A gentle consultation, product advice, and what to avoid is the appropriate outcome.
Event in 4–8 weeks
A conservative topical plan can be started carefully. No new aggressive products or procedures — reactions need time to settle. Focus on reducing active lesions gently. Camouflage and dermatologist-approved skincare advice for event day. Manage expectations: visible improvement is possible but unpredictable in this window.
Event in 3–6 months
An 8–16 week treatment course can show significant improvement before the event. PIH management can begin after active control is achieved. Gentle peels may be considered if acne responds well. Results are more predictable. This is the ideal minimum timeline for visible, stable improvement.
Event in 6–12 months
Full treatment course, maintenance, and early PIH/scar procedures can all be planned. Isotretinoin, if indicated, can complete a full course with time for skin to settle. This is the timeline within which the most comprehensive change is achievable. Plan your wedding skin consultation at least 9 months in advance.
Travel
If travelling internationally, ensure adequate medication supply is confirmed. Retinoid sensitivity increases sun risk — extra SPF diligence in tropical destinations. If on isotretinoin, travel with doctor contact details and monitoring records. Avoid aggressive procedures within 2 weeks of air travel.
Photoshoots
Avoid new actives, peels, or procedures within 3 weeks of a photoshoot. Redness and dryness from retinoid initiation or post-peel scaling are visible even with makeup. Non-comedogenic makeup is recommended. If acne is active, the dermatologist can advise on safe short-term management for skin appearance.
What makes DDC different from a general skin clinic
Grade before treatment
Every acne patient is graded using the GAGS system before any prescription is written. No standard package — treatment matches grade, skin type, and history.
Indian skin first
PIH risk in Indian skin guides every topical, peel, and procedure decision. Treatment intensity is calibrated for Fitzpatrick III–V, not imported wholesale from Western protocols.
Antibiotic discipline
Antibiotics are prescribed for the shortest appropriate duration, always in combination with retinoid and BPO. Long-term antibiotic monotherapy is not a DDC practice.
Scar prevention as priority
The most effective scar treatment is prevention. Early detection of deep acne that will scar guides escalation decisions before damage becomes irreversible.
Realistic counselling
No guarantee of permanent cure. No promise of results in days. Honest, grade-specific expectations are set at every consultation — because patient trust is built on reality, not promises.
Maintenance focus
Clearance is not the finish line. Every treatment plan includes a maintenance pathway to reduce relapse. The goal is sustained control, not one-time clearance.
Hormonal thinking
Adult female acne is assessed for hormonal drivers as a standard step — not an afterthought. PCOS, OCP history, and cyclic patterns are evaluated and addressed in the treatment plan.
No shortcut culture
We do not offer "quick clear" packages, aggressive procedures on inflamed skin, or scar treatment while acne is uncontrolled. Safe, evidence-informed sequencing is the only approach offered.
Specialist dermatologists — qualified, registered, experienced
All DDC doctors hold formal dermatology qualifications and medical council registration. This information is verified and publicly confirmable. No unqualified practitioners perform treatment.
Dr Chetna Ghura
MBBS, MD Dermatology
16 years experience
Medical Reviewer · Acne & cosmetology
Dr Kavita Mehndiratta
MBBS, DVD, FRHS, MIADVL
20 years experience
Skin care · Laser procedures
Dr Sachin Gupta
MBBS, MD Dermatology
Dermatology specialist
Acne · Scars · Laser · Vitiligo
Dr Aakansha Mittal
MBBS, D.D.V.L, MIADVL
3 years experience
Skin · Hair · Nails · Allergy
Dr Rinki Tayal
MBBS, DDVL Dermatology
2 years experience
Dermatology · Hair regrowth
Choose the right next step
Acne, acne scars, and pigmentation are three different conditions. Do not choose a scar or pigmentation page while active acne is still uncontrolled. The links below guide you to the correct pathway.
For boxcar, ice-pick, or rolling scars — after active acne is controlled. Separate pathway.
Pigmentation TreatmentFor post-acne dark marks (PIH) and uneven skin tone — managed alongside or after active acne.
Chemical PeelsFor comedonal acne, early PIH, and selected skin types — adjunct, not standalone treatment.
Dermatologist ConsultationIf you are unsure what is happening with your skin — start here before choosing a treatment.
Hormonal AcneFor adult female jawline, chin, and cyclic lower-face acne with a hormonal driver.
Back & Body AcneFor trunk acne influenced by sweat, friction, and sebaceous density on body skin.
Acne Treatment CostDetailed breakdown of starting price and cost factors for all acne treatment modalities.
Laser ToningFor selected post-acne redness, pigment, and oiliness — adjunct after acne control.
Skin ConsultationIf you are unsure which page is right for your concern — start with a skin consultation.
Honest answers before you book
These 20 questions cover what patients most often ask — about process, safety, results, cost, and local context. Every answer is written to stand alone in search results and AI overview extraction.
What is the best acne treatment in Delhi?
How long does acne treatment take?
Can acne be cured permanently?
Is isotretinoin safe?
Why do I get dark marks after every pimple?
Should I treat acne scars while pimples are active?
Can I get a chemical peel while acne is active?
Is acne treatment safe for Indian skin?
Does diet cause acne?
Can stress cause acne?
Why did antibiotics work, then my acne came back?
Can acne be hormonal in women?
What is GAGS grading?
What should I bring to my first consultation?
Can laser treat acne?
Will treatment cause purging?
Is acne treatment safe during pregnancy?
Are acne scars and dark marks the same thing?
When should treatment be paused or stopped?
What is the starting price for acne treatment?
How many procedure sessions will I need?
Will my treatment plan change after the first consultation?
What does DDC do that a general skin clinic does not?
What if I have already tried multiple treatments and nothing worked?
Is downloading the pre-treatment and post-treatment checklists necessary?
Why do I get acne on my back, chest, or shoulders, not just my face?
I am over 25 and still getting acne — why?
Do I really need sunscreen if my skin is oily and breaking out?
My acne started or worsened after wearing a mask. Is this real?
Can over-the-counter steroid creams make acne worse?
Will birth control pills help or worsen my acne?
What is the difference between blackheads and whiteheads?
Does Delhi pollution and weather affect my acne?
Public reference layer
This page draws on internationally recognised dermatology references for educational accuracy. It does not reproduce clinical guidelines verbatim and does not constitute personal medical advice.
- 1Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2016;74(5):945–973.
- 2Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. International Journal of Dermatology. 1997;36(6):416–418.
- 3American Academy of Dermatology — Acne patient education and clinical resources. Available at: aad.org/public/diseases/acne
- 4National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Acne overview. Available at: niams.nih.gov
- 5Nast A, Dréno B, Bettoli V, et al. European evidence-based guidelines for the treatment of acne. Journal of the European Academy of Dermatology and Venereology. 2012;26(S1):1–29.
- 6Hazarika N, Archana M. The psychosocial impact of acne vulgaris. Indian Journal of Dermatology. 2016;61(5):515–520.
- 7Sarkar R, Garg VK. Postinflammatory hyperpigmentation in patients with skin of color. Pigmentary Disorders. 2013. (Indian skin PIH reference)
- 8Bhate K, Williams HC. Epidemiology of acne vulgaris. British Journal of Dermatology. 2013;168(3):474–485.
- 9Costa CS, Bagatin E, Martimbianco ALC, da Silva EMK, Lúcio MM, Magin P, Riera R. Oral isotretinoin for acne. Cochrane Database of Systematic Reviews. 2018, Issue 11. Art. No.: CD009435.
- 10Walsh TR, Efthimiou J, Dréno B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infectious Diseases. 2016;16(3):e23–e33.
- 11Kubba R, Bajaj AK, Thappa DM, et al. Indian Acne Alliance: clinical recommendations for acne management in India. Indian Journal of Dermatology, Venereology and Leprology. 2009;75(Suppl 1):S1–S62.
- 12Saraswat A, Lahiri K, Chatterjee M, et al. Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients. Indian Journal of Dermatology, Venereology and Leprology. 2011;77(2):160–166.
- 13Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. Journal of Clinical and Aesthetic Dermatology. 2010;3(4):24–38.
- 14Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. American Journal of Clinical Nutrition. 2007;86(1):107–115.
- 15DDC clinical governance: All treatment content reviewed by named dermatologist. Medical registration numbers publicly verifiable. Offline clinical approvals maintained per DDC internal governance protocol.
Get a diagnosis before choosing a treatment
The next step is not choosing a treatment. The next step is understanding what grade your acne is, what is driving it, and what is realistic for your skin type and history. That happens in a consultation — not on a website.
- 30–45 minute dermatologist consultation
- GAGS grading and personalised written plan
- Product audit and trigger identification
- Realistic expectations and timeline discussion
- Starting from ₹1,999 — final cost explained at consultation
Book your consultation
By submitting this form, you agree to be contacted by our team. This form does not create a doctor-patient relationship.